Aug 2026· Clinica chimica acta; international journal of clinical chemistry· Vol 593, pp.
121297
· 0 citations· 95 references
Medicine
TL;DR
The present review focuses on the significance of ncRNAs as diagnostic markers for PCa and summarizes recent progress in biosensing technologies, emphasizing electrochemical methods designed to identify ncRNAs associated with this cancer.
Abstract
Prostate cancer (PCa) is a prevalent malignancy with high mortality, partly due to the lack of reliable diagnostic methods. In recent years, non-coding RNAs (ncRNAs) have gained recognition as promising indicators for accurate disease detection and outcome prediction, given their inherent stability and expression profiles that are specific to pathological states. To enable the measurement of these biomolecules, a range of biosensors especially electrochemical sensing systems have been developed, providing advantages such as high precision in diagnosis, fast response times, and low cost. The present review focuses on the significance of ncRNAs as diagnostic markers for PCa and summarizes recent progress in biosensing technologies, emphasizing electrochemical methods designed to identify ncRNAs associated with this cancer.
Prostate cancer (PCa) is one of the most prevalent malignancies among men worldwide. Although prostate-specific antigen (PSA) testing has improved early detection of PCa, its limited specificity leads to false positives and false negatives, resulting in overdiagnosis and unnecessary biopsies. These limitations highligh...
Cancer remains among the leading causes of mortality globally, where the detection of biomarkers is essential for early diagnosis and accurate prognosis. Among them, microRNA-21 (miR-21) is a clinically significant oncogenic biomarker that is dysregulated across various cancers, highlighting the need for rapid, sensiti...
Gopi Karuppaiah, Aneesh Koyappayil, S. Chavan et al.· Bioelectrochemistry· 0 citations
This review critically presents the fundamental principles, sensor configurations, and applications of optical biosensors for cancer detection and monitoring, with particular emphasis on technological advances that underpin sensitivity, specificity, multiplexing, and clinical translation.
H. Saputra, Md Ali Zaber Sahin, Y. Hartati· Clinica chimica acta; intern...· 0 citations
This work highlights strategies specifically designed for epithelial-mesenchymal transition (EMT)-associated CTC phenotypes and explores AI- and IoT-enabled implementations for decentralized oncology, and a comprehensive evaluation of electrochemical approaches for CTC and ctDNA detection.
Tuğba Ören Varol, Mehmet Varol· Annals of Biomedical Enginee...· 0 citations
Detection of tumor biomarkers in serum and cellular samples is essential for early diagnosis and precision treatment of colorectal cancer, and miRNA-21 is well-established as a pivotal oncogenic biomarker for this malignancy. Conventional nucleic acid detection methods typically rely on complex enzymatic amplification...
Nan Ma, Yue-Lan Fang, Xiao-Ran Wu et al.· Analytica Chimica Acta· 0 citations
Early screening of many types of cancers remains limited by the invasiveness of gold-standard tissue biopsies and the poor specificity of traditional clinical biomarkers like prostate-specific antigen (PSA). Non-invasive liquid biopsies are the emerging alternatives. Urine is one of the preferred body fluids for liquid...
Eleni Lamprou, Dimitrios Papakyriakou, D. Kalogianni· Italian National Conference...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.